BACKGROUND The infection with Trichomonas Vaginalis is one of the most common sexually transmitted diseases (STDs) in humans. The prevalence of this infection has been reported to be between 2 to 8%, depending on the different socio-cultural conditions. This study aimed to determine the prevalence of T. vaginalis in the women who were referred to the gynaecologic clinics at the MVJ medical coll...

Metronidazole (8823 RP; "Flagyl") is a nitroinidazole derivative which has been shewn to be highly active against T. vaginalis, not only in the laboratory (Cosar and Julou, 1959) but also in vivo against human trichomoniasis in the female (Durel, Roiron, Siboulet, and Borel, 1959, 1960; Durel, Couture, Collart, and Girot, 1960; Nicol, Barrow, and Redmond, 1960; Rodin, King, Nicol, and Barrow, 1...

background: infection with trichomonas vaginalis is one of the most common sexually transmitted diseases (stds) in humans. the prevalence of infection in iran has been reported between 2 to 8%, depending on deferent socio-cultural conditions. this study aimed to determine the prevalence of t . vaginalis in women referred to gynecologic clinics in hamadan city, west of iran. methods: this descri...

BACKGROUND Trichomoniasis is the most common sexually transmitted protozoan diseases in the worldwide. Metronidazole is the choice drug for trichomoniasis treatment, however, metronidazole resistant Trichomonas vaginalis (T.vaginalis) has been reported. Natural products are the source of most new drugs, and Zingiber officinale (Ginger) is widely used ingredient in the traditional medicine. OB...

OBJECTIVES Complex interactions of vaginal microorganisms with the genital tract epithelium shape mucosal innate immunity, which holds the key to sexual and reproductive health. Bacterial vaginosis (BV), a microbiome-disturbance syndrome prevalent in reproductive-age women, occurs commonly in concert with trichomoniasis, and both are associated with increased risk of adverse reproductive outcom...

The antibody response in trichomoniasis patients was examined with a variety of methodologies including enzyme-linked immunosorbent assays, indirect immunofluorescence, immunoblotting, and radioimmunoprecipitation-electrophoresis-autoradiography. Based on enzyme-linked immunosorbent assay recognition of trichomonal isolates, sera from patients with trichomoniasis were categorized into reactive ...

Trichomonas vaginalis (Tv) is a parasitic protozoan that infects the genitourinary tract and produces the most common curable sexually transmitted disease (STD) in sexually active women in all age groups (1). Globally, trichomoniasis affects approximately 57-180 million people, with the majority living in developing countries (2,3). It is predominantly spread via unprotected intercourse with an...

1. Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3. Dep. Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4. Dept. of Health and Community Med...

Vaginal trichomoniasis is a highly prevalent sexually transmitted disease caused by a microaerophilic protozoan Trichomonas vaginalis. The disease is one of the most common sexually transmitted disease and can augment the predisposition of individuals to human immunodeficiency virus (HIV) infection. Although the disease can be treated with metronidazole and related 5-nitroimidazole, cases of tr...

BACKGROUND Trichomoniasis vaginalis, the most prevalent nonviral sexually transmitted infection, is associated with negative reproductive outcomes and increased HIV transmission and may be overrepresented among African Americans. METHODS A total of 135 African American women who used drugs were screened for Trichomonas vaginalis on > or =2 occasions between March 2003 and August 2005. Women w...